(19)
(11) EP 1 294 690 A2

(12)

(88) Date of publication A3:
30.05.2002

(43) Date of publication:
26.03.2003 Bulletin 2003/13

(21) Application number: 01950360.6

(22) Date of filing: 20.06.2001
(51) International Patent Classification (IPC)7: C07D 211/14, C07D 211/18, C07D 207/06, C07D 401/06, C07D 401/12, C07D 417/12, C07D 211/34, C07D 211/52, C07D 405/06, C07D 413/12, C07D 403/12, A61K 31/4545, A61P 29/00, A61P 11/06
(86) International application number:
PCT/US0119/752
(87) International publication number:
WO 0109/8270 (27.12.2001 Gazette 2001/52)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.06.2000 US 213208 P
21.06.2000 US 597400

(71) Applicant: Bristol-Myers Squibb Pharma Company
Princeton,New Jesey 08543-4000 (US)

(72) Inventors:
  • KO, Soo, S.
    Hockessin, DE 19707 (US)
  • DELUCCA, George, V.
    Wilmington, DE 19810 (US)
  • DUNCIA, John, V.
    Hockessin, DE 19707 (US)
  • KIM, Ui, Tae
    Kalamazoo, MI 49001 (US)
  • WACKER, Dean, A.
    Chadds Ford, PA 19317 (US)
  • ZHENG, Changsheng
    Wilmington, DE 19803 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY